4//SEC Filing
Vitality Biopharma, Inc. 4
Accession 0001638599-16-001292
$RNGECIK 0001438943operating
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:05 PM ET
Size
10.7 KB
Accession
0001638599-16-001292
Insider Transaction Report
Form 4
Brooke Robert T.
VP of Business Devevlopment
Transactions
- Award
Option Award (right to buy)
2015-05-21+40,000→ 40,000 totalExercise: $2.10From: 2015-05-21Exp: 2025-05-21→ common stock (40,000 underlying) - Award
Option Award (right to buy)
2016-07-15+415,000→ 455,000 totalExercise: $0.50From: 2017-01-01Exp: 2026-07-15→ common stock (415,000 underlying) - Award
Restricted Stock Unit Award
2016-07-15+510,585→ 965,585 totalExercise: $0.00→ common stock (510,585 underlying)
Footnotes (4)
- [F1]Of the 40,000 options granted on May 21, 2015, 10,000 vested on each of November 21, 2015 and May 21, 2016 and 100,000 will vest on each of November 21, 2016, and May 21, 2017
- [F2]Of the 415,000 options granted on July 15, 2016, 103,750 options will vest on each of January 1, 2017, July 1, 2017, January 1, 2018, and July 1, 2018
- [F3]Each Restricted Stock Unit (RSU) represents the right to receive, at settlement, one share of common stock. This transaction represents the issuance of RSUs, rather than the issuance of shares in common stock, which will occur on their scheduled vesting date
- [F4]Of the 510,585 of the RSUs, 255,293 will vest on March 1, 2017, and 255,292 will vest on March 1, 2018. The RSU will vest immediately upon a corporate change of control, or if the individual is terminated for any reason other than a "For Cause" termination
Documents
Issuer
Vitality Biopharma, Inc.
CIK 0001438943
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001438943
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:05 PM ET
- Size
- 10.7 KB